Manjari Mishra | Nano Drug Delivery | Best Researcher Award

Dr. Manjari Mishra, Nano Drug Delivery, Best Researcher Award

Doctorate at stanford school of medicine, United States

Summary:

Dr. Manjari Mishra is a highly accomplished researcher specializing in biophysics, chemical biology, and pharmaceutical biotechnology. She obtained her Doctor of Natural Sciences (Ph.D.) in Biophysics and Chemical Biology from the Indian Institute of Technology Bombay, where she received the Best Ph.D. Thesis award in Chemistry for her outstanding research contributions. Dr. Mishra’s research focuses on understanding viral pathogenesis, host-pathogen interactions, and the development of novel antiviral strategies. She has extensive experience as a Postdoctoral Research Fellow at the Stanford School of Medicine, USA, where she investigates the role of lipid kinases in the life cycle of coronaviruses. Dr. Mishra’s interdisciplinary research interests also extend to chemical biology, drug discovery, and environmental remediation. With a track record of prestigious awards, fellowships, and research publications, Dr. Manjari Mishra is recognized for her dedication to advancing scientific knowledge and addressing critical challenges in biomedicine and environmental science.

Professional Profile:

šŸ‘©ā€šŸŽ“Education:

Doctor of Natural Sciences (Ph.D.)

  • Field: Biophysics and Chemical Biology
  • Institution: Indian Institute of Technology Bombay, India
  • Year: July 2017 ā€“ Aug 2022

Master of Pharmacy (MS Pharma)

  • Field: Pharmaceutical Biotechnology
  • Institution: National Institute of Pharmaceutical Education & Research, India
  • Year: July 2013 ā€“ July 2015
  • Ranking: 3rd in class

Bachelor of Pharmacy (B. Pharma)

  • Field: Pharmacy
  • Institution: Dr. APJ Abdul Kalam Technical University, India
  • Year: June 2007 ā€“ June 2011
  • Class: First Class, 72.14/100

Professional Experience:

Dr. Manjari Mishra is an accomplished researcher with extensive professional experience in the fields of biophysics, chemical biology, and pharmaceutical biotechnology. Following her doctoral studies, she served as a Postdoctoral Research Fellow at the Stanford School of Medicine in the USA, where she focused on investigating the role of lipid kinases in the life cycle of coronaviruses and their potential as targets for broad-spectrum antiviral strategies. Prior to her postdoctoral appointment, Dr. Mishra conducted research on modulating host signaling pathways using mycobacterial virulent lipids as part of her Ph.D. project at the Indian Institute of Technology Bombay. Additionally, she has experience as a Junior Research Fellow, where she worked on projects related to the removal of endocrine disruptor pharmaceuticals from water and designing ophthalmic products. Dr. Mishra’s diverse research portfolio, coupled with her academic accolades and prestigious fellowships, underscores her expertise and commitment to advancing scientific knowledge in her field.

Research Interest:

Viral Pathogenesis and Antiviral Strategies: Dr. Mishra is interested in understanding the molecular mechanisms underlying viral infections, particularly focusing on the life cycle of coronaviruses. She explores the role of lipid kinases and other host factors in viral replication and pathogenesis, with the aim of developing novel antiviral therapies.

Host-Pathogen Interactions: She investigates the interactions between pathogens and host cells, including how pathogens modulate host signaling pathways to promote their survival and replication. Dr. Mishra’s research aims to identify potential targets for therapeutic intervention to disrupt these interactions and inhibit pathogen replication.

Chemical Biology and Drug Discovery: Dr. Mishra is involved in the development of chemical biology tools and strategies to modulate host cellular pathways. She is interested in designing small molecules and inhibitors targeting specific cellular components involved in disease pathogenesis, with a focus on infectious diseases and cancer.

Biopharmaceuticals and Biotechnology: She explores the use of biopharmaceuticals and biotechnological approaches for the development of novel therapeutics and drug delivery systems. This includes research on the formulation and delivery of pharmaceutical products, as well as the development of biotechnological platforms for drug discovery and development.

Environmental Remediation: Dr. Mishra is interested in environmental applications of biotechnology, such as the removal of pharmaceutical contaminants from water using nanomaterials and other advanced techniques. Her research aims to develop sustainable and efficient methods for environmental remediation.

Publications Top Noted:Ā 

Title: Dynamic remodeling of the host cell membrane by virulent mycobacterial sulfoglycolipid-1

  • Authors: M Mishra, P Adhyapak, R Dadhich, S Kapoor
  • Journal: Scientific reports
  • Volume: 9
  • Issue: 1
  • Pages: 12844
  • Year: 2019
  • Citations: 27

Title: Dynamical organization of compositionally distinct inner and outer membrane lipids of mycobacteria

  • Authors: P Adhyapak, AT Srivatsav, M Mishra, A Singh, R Narayan, S Kapoor
  • Journal: Biophysical journal
  • Volume: 118
  • Issue: 6
  • Pages: 1279-1291
  • Year: 2020
  • Citations: 25

Title: Design and expeditious synthesis of quinolineā€pyreneā€based ratiometric fluorescent probes for targeting lysosomal pH

  • Authors: PE Hande, M Mishra, F Ali, S Kapoor, A Datta, SJ Gharpure
  • Journal: ChemBioChem
  • Volume: 21
  • Issue: 10
  • Pages: 1492-1498
  • Year: 2020
  • Citations: 19

Title: Biophysical characterization of mycobacterial model membranes and their interaction with rifabutin: Towards lipid-guided drug screening in tuberculosis

  • Authors: R Dadhich, A Singh, AP Menon, M Mishra, CD Athul, S Kapoor
  • Journal: Biochimica et Biophysica Acta (BBA)-Biomembranes
  • Volume: 1861
  • Issue: 6
  • Pages: 1213-1227
  • Year: 2019
  • Citations: 15

Title: A Virulence-associated glycolipid with distinct conformational attributes: Impact on lateral organization of host plasma membrane, autophagy and signaling

  • Authors: M Mishra, R Dadhich, S Ning, S Jana, VA Sarpe, J Mahato, M Duan
  • Journal: ACS Chemical Biology
  • Year: 2020
  • Citations: 13

Federica Rinaldi | Nanomedicine Award | Best Researcher Award

Assoc Prof Dr. Federica Rinaldi, Nanomedicine Award, Best Researcher Award

Associate Professor at Sapienxa University of Rome, Italy

Summary:

Dr. Federica Rinaldi is an Associate Professor in the Department of Chemistry and Technologies of Drugs at Sapienza University of Rome. She obtained her Ph.D. in Pharmaceutical Sciences from the University of Rome “La Sapienza” in 2012, with a focus on novel targeting strategies using vesicles and synthetic surfactants. Dr. Rinaldi’s research interests span various aspects of pharmaceutical sciences, including nanotechnology for drug delivery, formulation development, targeted drug delivery systems, pharmacokinetics, pharmacodynamics, and pharmaceutical technology legislation. She is actively involved in teaching and mentoring students at both undergraduate and graduate levels. Dr. Rinaldi is a member of several professional societies and has received recognition for her contributions to nanotechnology and drug delivery research. Her work aims to advance pharmaceutical sciences and improve therapeutic outcomes through innovative drug delivery approaches.

Professional Profile:

Scopus Profile

Orcid Profile

šŸ‘©ā€šŸŽ“Education & Qualification:

University Graduation (2008):

  • Institution: University of Rome “La Sapienza”
  • Degree: Chemistry and Pharmaceutical Technologies
  • Faculty: Faculty of Pharmacy

License (2009):

  • Institution: University of Rome “La Sapienza”
  • License: License to practice the profession of Pharmacist

PhD (2012):

  • Institution: University of Rome “La Sapienza”
  • Degree: Pharmaceutical Sciences
  • Department: Department of Drug Chemistry and Technologies, Faculty of Pharmacy

Professional Experience:Ā Ā 

Dr. Federica Rinaldi has extensive professional experience in academia and research. She currently serves as an Associate Professor in Pharmaceutical Technologies at the Department of Chemistry and Technologies of Drug at Sapienza University of Rome. Prior to this, she held the position of National Scientific Qualification (ASN) as an associate professor at the Ministero dell’Istruzione dell’UniversitĆ  e della Ricerca (MIUR). Dr. Rinaldi has been actively involved in teaching and research, contributing significantly to the field of pharmaceutical sciences. She has supervised laboratory experiences, courses, and seminars at various institutions, including the University of Rome “La Sapienza” and Tor Vergata University of Rome. Additionally, she has served as a member of examination commissions and has been recognized for her contributions to nanotechnology and drug delivery by the European Commission. Dr. Rinaldi’s dedication to academia and research is evident through her numerous memberships in professional societies and her continuous commitment to innovative teaching methodologies.

Research Interest:

Nanotechnology for Drug Delivery: Dr. Rinaldi is interested in exploring innovative nanocarriers and vesicles for drug delivery applications, with a particular emphasis on improving drug targeting and bioavailability.

Formulation Development: She investigates novel formulation strategies to enhance the stability, efficacy, and safety of pharmaceutical products, including nanoemulsions, niosomes, and other nanocarrier systems.

Targeted Drug Delivery Systems: Dr. Rinaldi explores advanced targeting strategies to achieve site-specific drug delivery, including pH-sensitive vesicles and ligand-mediated drug targeting approaches.

Pharmacokinetics and Pharmacodynamics: She studies the pharmacokinetic and pharmacodynamic properties of drug formulations, aiming to optimize drug release kinetics and therapeutic outcomes.

Pharmaceutical Technology and Legislation: Dr. Rinaldi is involved in research related to pharmaceutical technology advancements, as well as the regulatory aspects governing pharmaceutical products, including legislation and quality control.

Publication Top Noted:

Effect of Ciprofloxacin-Loaded Niosomes on Escherichia coli and Staphylococcus aureus Biofilm Formation

  • Authors: Maurizi, L., Forte, J., Ammendolia, M.G., Carafa, M., Longhi, C.
  • Journal: Pharmaceutics
  • Year: 2022
  • Volume: 14
  • Issue: 12
  • Pages: 2662

Ultrastable shelled PFC nanobubbles: A platform for ultrasound-assisted diagnostics, and therapy

  • Authors: Hanieh, P.N., Ricci, C., Bettucci, A., Del Favero, E., Marianecci, C.
  • Journal: Nanomedicine: Nanotechnology, Biology, and Medicine
  • Year: 2022
  • Volume: 46
  • Pages: 102611

Almond oil O/W nanoemulsions: Potential application for ocular delivery

  • Authors: Hanieh, P.N., Bonaccorso, A., Zingale, E., Pignatello, R., Carafa, M.
  • Journal: Journal of Drug Delivery Science and Technology
  • Year: 2022
  • Volume: 72
  • Pages: 103424

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment

  • Authors: Hanieh, P.N., Consalvi, S., Forte, J., Carafa, M., Marianecci, C.
  • Journal: Pharmaceutics
  • Year: 2022
  • Volume: 14
  • Issue: 3
  • Pages: 610

pH-responsive oleic acid based nanocarriers: Melanoma treatment strategies

  • Authors: Rinaldi, F., Forte, J., Pontecorvi, G., Puglisi, R., Carafa, M.
  • Journal: International Journal of Pharmaceutics
  • Year: 2022
  • Volume: 613
  • Pages: 121391